This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hotta, M. Articles by Takano, K. Search for Related Content PubMed PubMed Citation Articles by Hotta, M. Articles by Takano, K.

The Relationship between Bone Turnover and Body Weight, Serum Insulin-Like Growth Factor (IGF) I, and Serum IGF-Binding Protein Levels in Patients with Anorexia Nervosa¹

Department of Medicine, Institute of Clinical Endocrinology, Tokyo Women’s Medical University School of Medicine, 8–1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666; and Department of Physiology, Nippon Medical School (T.S.), 1–1-5 Sendagi, Bunkyo-ku, 113-8602, Japan

Address all correspondence and requests for reprints to: Mari Hotta, M.D., Department of Medicine, Institute of Clinical Endocrinology, Tokyo Women’s Medical University School of Medicine, 8–1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan. E-mail: BZI00174{at}niftyserve.or.jp

Malnutrition is one of the risk factors for bone loss in patients with anorexia nervosa (AN). To clarify the effects of nutritional status on bone metabolism, we examined the relationship between serum levels of nutritional indicators [insulin-like growth factor I (IGF-I), IGF-binding protein-2 (IGFBP-2), and IGFBP-3] and markers for bone metabolism [serum osteocalcin and urinary excretion of C-terminal telopeptide of collagen type I (CrossLaps)] in 45 AN out-patients, including 8 severely malnourished patients who required hospitalization and iv hyperalimentation (IVH).

Compared to healthy subjects, serum IGF-I and IGFBP-3 were lower, whereas IGFBP-2 was higher in out-patients who had a body mass index (BMI) less than 16.5 kg/m². In these patients, urinary excretion of CrossLaps, a marker of bone resorption, was higher, whereas serum osteocalcin, a marker of bone formation, was lower than those in control subjects. All of these parameters were normal in patients whose BMI ranged from 16.5–18.5 kg/m². Serum levels of osteocalcin correlated positively with BMI (r = 0.512; P < 0.0001), IGF-I (r = 0.558; P < 0.0001), and IGFBP-3 (r = 0.369; P < 0.001) in AN out-patients. In the 8 severely malnourished AN patients, serum levels of IGF-I and osteocalcin significantly increased 3 and 7 days, respectively, after the start of a 5-week IVH therapy regimen and reached normal levels within 5 weeks, accompanied by still elevated urinary excretion of CrossLaps.

The present study demonstrates that an improvement in nutritional status in AN patients during IVH therapy rapidly increases the serum IGF-I levels, followed by a progressive increase in osteocalcin, suggesting immediate start of bone formation. However, increased bone resorption appears to continue for at least 5 weeks.

This article has been cited by other articles:

				J. Dominguez, L. Goodman, S. Sen Gupta, L. Mayer, S. F. Etu, B T. Walsh, J. Wang, R. Pierson, and M. P Warren Treatment of anorexia nervosa is associated with increases in bone mineral density, and recovery is a biphasic process involving both nutrition and return of menses Am. J. Clinical Nutrition, July 1, 2007; 86(1): 92 - 99. [Abstract] [Full Text] [PDF]

				M. Hotta, R. Ohwada, H. Katakami, T. Shibasaki, N. Hizuka, and K. Takano Plasma Levels of Intact and Degraded Ghrelin and Their Responses to Glucose Infusion in Anorexia Nervosa J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5707 - 5712. [Abstract] [Full Text] [PDF]

				M. Heer, C. Mika, I. Grzella, N. Heussen, and B. Herpertz-Dahlmann Bone turnover during inpatient nutritional therapy and outpatient follow-up in patients with anorexia nervosa compared with that in healthy control subjects Am. J. Clinical Nutrition, September 1, 2004; 80(3): 774 - 781. [Abstract] [Full Text] [PDF]

				S. Grinspoon, K. Miller, D. Herzog, D. Clemmons, and A. Klibanski Effects of Recombinant Human Insulin-Like Growth Factor (IGF)-I and Estrogen Administration on IGF-I, IGF Binding Protein (IGFBP)-2, and IGFBP-3 in Anorexia Nervosa: A Randomized-Controlled Study J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1142 - 1149. [Abstract] [Full Text] [PDF]

				C. M. Gordon, E. Grace, S. J. Emans, H. A. Feldman, E. Goodman, K. A. Becker, C. J. Rosen, C. M. Gundberg, and M. S. LeBoff Effects of Oral Dehydroepiandrosterone on Bone Density in Young Women with Anorexia Nervosa: A Randomized Trial J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 4935 - 4941. [Abstract] [Full Text] [PDF]

				S. Grinspoon, L. Thomas, K. Miller, D. Herzog, and A. Klibanski Effects of Recombinant Human IGF-I and Oral Contraceptive Administration on Bone Density in Anorexia Nervosa J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2883 - 2891. [Abstract] [Full Text] [PDF]

				S. Grinspoon, E. Thomas, S. Pitts, E. Gross, D. Mickley, K. Miller, D. Herzog, and A. Klibanski Prevalence and Predictive Factors for Regional Osteopenia in Women with Anorexia Nervosa Ann Intern Med, November 21, 2000; 133(10): 790 - 794. [Abstract] [Full Text] [PDF]

				G. R. Mundy Secondary Osteoporosis: The Potential Relevance of Leptin and Low Body Weight Ann Intern Med, November 21, 2000; 133(10): 828 - 830. [Full Text] [PDF]